CRISPR Gets an Upgrade Thanks to “Jumping Genes”
The Context: CRISPR is a powerful, ‘word-processor’-like tool for editing DNA, but currently it is much easier to eliminate undesired sequences than it is to accurately...
1041 Results
NYSCF Collaboration Discovers New Mechanism for Helping Stem Cells Enhance Their “Stem-ness”
The Context: What makes stem cells special is their ability to turn into other cell types in the body (a characteristic called “pluripotency”). Our understanding of...
NYSCF Collaboration Identifies Promising Drug for Treating Most Common Form of Macular Degeneration
The Context: Age-related macular degeneration (AMD) is a disease which affects 8 million Americans and can lead to severe vision loss due to death of retinal...
Gene Editing: The Science, Ethics, and Promise of a Revolutionary Technology
Perhaps in the past few years, you’ve started to hear more about CRISPR gene editing— the revolutionary technique that allows us to precisely manipulate the DNA...
Inspiring the Next Generation of Scientists: NYSCF Hosts Second Annual Family Stem Cell Day
“Who thinks I can power this lightbulb with just the electricity from my finger?” Dr. Cecile Terrenoire asks a crowded room of eager students. About half...
Protecting Premature Babies from Brain Damage
The Context: It is estimated that 15 million babies are born prematurely each year, and a common premature birth complication is low oxygen levels. We know...
NYSCF Hosts Launch of Jamie Metzl’s New Book: “Hacking Darwin: Genetic Engineering and the Future of Humanity”
“After 3.8 billion years of evolving by Darwinian principles, we are turning a corner and taking more control over all biology, including our own,” explained Jamie...
Speak Your Mind: Edward Chang Pioneers Device That Translates Brain Activity Into Speech
The Context: Patients suffering from stroke, paralysis, ALS, Parkinson’s, and many other conditions are often left with impaired speaking and gesturing abilities, and there are few...
Stem Cells, Alzheimer’s, and Caregiving: Susan L. Solomon Guests Stars on the “Thank You Dan and Alex” Podcast
“Stem cells allow us to understand what exactly is broken, and therefore, what needs to be fixed,” NYSCF CEO Susan L. Solomon explained. “The problem with...
Taking on Type 1 Diabetes: Researchers and Patient Advocates Unite in the Quest for a Cure
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
A Gut Feeling: Zachary Knight Discovers That Thirst is Controlled by Signals in the Gastrointestinal Tract
The Context: The brain has “thirst neurons” that help us know when we need water and when we don’t. But how these neurons receive information from...
Shifting Paradigms in Research and Treatment of Women’s Reproductive Cancers
Women’s reproductive cancers—such as ovarian cancer, endometrial cancer, uterine cancer, and cervical cancer—are especially difficult to treat. Mortality rates are high (32,000 women die from these...
Participate in Type 1 Diabetes Research
The New York Stem Cell Foundation Research Institute is recruiting for a stem cell research study. Eligible individuals will have type 1 diabetes. The purpose of...
NYSCF–Druckenmiller Alumna Maria Themeli is Paving the Way to Democratize Access to Cancer Treatments
Maria Themeli, MD, PhD, believes that everyone, no matter their financial situation, should have access to effective cancer treatments. Because of this, she is working to...
Dr. Feng Zhang Launches New CRISPR Biotech to Create Better Diagnostic Tools
NYSCF – Robertson Stem Cell Investigator, CRISPR pioneer, and MIT Professor of Brain and Cognitive Sciences and Biological Engineering Dr. Feng Zhang and his collaborators have...
Scientists Reconnect at Inaugural NYSCF – Robertson Investigator Alumni Meetings
Building a strong community of researchers committed to advancing cutting-edge science is critical for getting treatments and cures to patients as quickly as possible. Because of...
Supporting 30 Million Patients on Rare Disease Day
“At the current rate of therapeutic development for rare diseases, it will be 2000 years before doctors won’t have to say to patients, ‘There’s nothing more...
The Science of Startups: Drs. Derrick Rossi and Paul Tesar Discuss How Their Biotechs Are Bringing Stem Cell Research to Patients
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...
NYSCF Collaboration Uncovers New Target for Progressive Multiple Sclerosis Therapies
The Context: In multiple sclerosis, the immune system attacks myelin (the fatty substance that surrounds neurons and helps them send signals). Currently, there are no...
What Can Singing Mice Teach Us About Human Conversation?
The Context: The brain activity that enables the rapid back-and-forth of human conversation is likely disrupted in diseases or disorders that interfere with normal communication such...
NYSCF Hosts Panel Discussion on the Future of Alzheimer’s Research and Treatment
44 million people worldwide are affected by Alzheimer’s. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is...
NYSCF Rings NASDAQ Opening Bell
This morning, NYSCF CEO Susan L. Solomon rang the NASDAQ bell to officially open stock trading for the day. “I’m incredibly optimistic about the future of...
Building New York City’s Life Science Community
This month, NYSCF CEO Susan L. Solomon, JD, spoke at the NYC Builds Bio+ February Quarterly Breakfast (held at the New York Genome Center) about NYSCF’s...
NYSCF Hosts LaunchBio’s “Invest in Cures”
Curing disease takes more than just research– it requires well-planned investment and business strategies that allow science to get done and treatments to move out of...
Using Stem Cells and Gene Editing to Fight Neonatal Diabetes
The Context: Neonatal diabetes affects between 1 and 5 percent of all diabetes patients. It is caused by a single genetic mutation that prevents pancreatic beta...